Immutep Limited
IMMPNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $470.90M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.29$9.18
- Volume (live)
- -
- Avg. volume (3M)
- 20.20K
Immutep (IMMP) Stock Price & Financial Analysis
Immutep Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.10 - $3.23 |
|---|---|
| 52-Week High | $9.18 |
| 52-Week Low | $0.29 |
| Open | $3.21 |
| Volume (last close) | 7.94K |
| Average Volume (3M) | 20.20K |
| Revenue (TTM) | 15.26M |
|---|---|
| Net Income (TTM) | -99.36M |
| Free Cash Flow (TTM) | -84.05M |
| EPS (TTM) | −$13.57 |
| Profit Margin | -650.96% |
| Operating Margin | -977.17% |
| Return on Equity (ROE) | -229.51% |
| Debt to Equity | 0.02 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 470.90M |
|---|---|
| Shares Outstanding | 147.16M |
| Price to Sales (P/S) | 30.85 |
| Price to Book (P/B) | 10.88 |
| EV/EBITDA | -4.12 |
| 50-Day MA | $6.00 |
|---|---|
| 200-Day MA | $3.51 |
| 1-Year Change | +57.71% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Immutep at a Glance
As of the Oct 23, 2026 close, Immutep (IMMP) has a market capitalization of $470.90M. The stock trades at 30.9× sales. Over the trailing twelve months it lost $99.36M on revenue of $15.26M and burned $84.05M of free cash flow. Revenue grew 295.2% year over year.
As of its latest reported balance sheet, it holds $44.80M in cash and securities against $731.07K of debt, a net cash position of $44.07M.
Immutep does not currently pay a dividend.
The share price is up 57.7% over the past year. At $3.20 (the Oct 23, 2026 close) it sits within its 52-week range of $0.29 to $9.18, below its 200-day moving average of $3.51.
Frequently Asked Questions About Immutep
What is the current stock price for IMMP?
As of the Oct 23, 2026 close, IMMP stock trades at $3.20. The 52-week range is $0.29–$9.18, with a day range of $3.10–$3.23.
What is the P/E ratio for IMMP?
The P/E ratio (Price-to-Earnings) for IMMP is shown in the Key Statistics section. This valuation metric helps compare Immutep Limited to industry peers.
Does IMMP pay dividends?
Immutep does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMMP?
Analyst ratings and recommendations for IMMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IMMP?
As of the Oct 23, 2026 close, Immutep's market capitalization is $470.9M, classifying it as a small-cap company. Immutep operates in the Healthcare sector within the Biotechnology industry.